TargetMol

TargetMol logo

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain,professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening. We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Company Website

Product Listing

(2-Pyridyldithio)-PEG4-propargyl 100 mg  | Purity Not Available

TargetMol

(2-Pyridyldithio)-PEG4-propargyl is a polyethylene glycol (PEG)-based linker specifically designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs) [1].

More Information Supplier Page

(2-Pyridyldithio)-PEG4-propargyl 500 mg  | Purity Not Available

TargetMol

(2-Pyridyldithio)-PEG4-propargyl is a polyethylene glycol (PEG)-based linker specifically designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs) [1].

More Information Supplier Page

(20R)-Protopanaxadiol 1 mL  | 99.97%

TargetMol

1. Protopanaxdiol has the effect of anti-tumor through increasing the activity of body immunity, inhibiting tumor interstitial microvascular density and its proliferation activity, improving the lymphocyte transformation, the activity of NK cells and the contents of IL-2 significantly. 2. Protopanaxdiol prevents and heals obesity, fatty liver and hypertriglyceridemia in mice fed with a high-fat diet.

More Information Supplier Page

(20R)-Protopanaxadiol 20 mg  | 99.97%

TargetMol

1. Protopanaxdiol has the effect of anti-tumor through increasing the activity of body immunity, inhibiting tumor interstitial microvascular density and its proliferation activity, improving the lymphocyte transformation, the activity of NK cells and the contents of IL-2 significantly. 2. Protopanaxdiol prevents and heals obesity, fatty liver and hypertriglyceridemia in mice fed with a high-fat diet.

More Information Supplier Page

(20S)-Protopanaxadiol 50 mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 100 mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 10 mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 5 mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 1 mL  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxatriol 1 mL  | 98.12%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(20S)-Protopanaxatriol 25 mg  | 98.12%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(20S)-Protopanaxatriol 100 mg  | 98.12%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(20S)-Protopanaxatriol 10 mg  | 98.12%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(20S)-Protopanaxatriol 50 mg  | 98.12%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(20S)-Protopanaxatriol 5 mg  | 98.12%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid 5 mg  | Purity Not Available

TargetMol

(22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid (compound 15) is an antitubercular agent with MIC value of 12.5 μg/mL for Mycobacterium tuberculosis H37Ra. (22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid shows cytotoxicity with IC 50 value of 32 μM for Vero cells [1] .

More Information Supplier Page

(22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid 50 mg  | Purity Not Available

TargetMol

(22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid (compound 15) is an antitubercular agent with MIC value of 12.5 μg/mL for Mycobacterium tuberculosis H37Ra. (22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid shows cytotoxicity with IC 50 value of 32 μM for Vero cells [1] .

More Information Supplier Page